tiprankstipranks
Trending News
More News >
Inhibrx Biosciences, Inc. (INBX)
NASDAQ:INBX
US Market

Inhibrx Biosciences Inc (INBX) Income Statement

Compare
58 Followers

Inhibrx Biosciences Inc Income Statement

Last quarter (Q4 2025), Inhibrx Biosciences Inc's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Inhibrx Biosciences Inc's net income was $-32.83M. See Inhibrx Biosciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.30M$ 200.00K$ 1.80M$ 2.19M$ 7.13M
Gross Profit
$ -1.18M$ -2.08M$ 609.00K$ -107.99M$ 4.44M
Operating Expenses
$ 133.84M$ 329.36M$ 219.83M$ 21.12M$ 12.34M
Depreciation and Amortization
$ 2.48M$ 2.29M$ 1.19M$ 1.23M$ 1.20M
EBITDA
$ -135.03M$ 1.70B$ -206.69M$ -125.82M$ -75.37M
Operating Income
$ -135.03M$ -331.45M$ -219.22M$ -129.12M$ -76.56M
Other Income/Expenses
$ -5.03M$ 2.02B$ -20.50M$ -16.11M$ -5.20M
Pretax Income
$ -140.05M$ 1.69B$ -239.72M$ -145.22M$ -81.77M
Net Income
$ -140.06M$ 1.69B$ -241.36M$ -145.23M$ -81.77M
Per Share Metrics
Basic EPS
$ -9.04$ 116.58$ -5.12$ -3.62$ -2.15
Diluted EPS
$ -9.04$ 116.58$ -5.12$ -3.62$ -2.15
Weighted Average Shares Outstanding
15.49M 14.48M 47.13M 40.11M 38.01M
Weighted Average Shares Outstanding (Diluted)
15.49M 14.48M 47.13M 40.11M 38.01M
Currency in USD

Inhibrx Biosciences Inc Earnings and Revenue History